Press release
Animal Nutrition
September 11, 2019

Easy monitoring of health and microbial status of poultry flocks thanks to new ScreenFloX® service from Evonik

  • Improved livestock monitoring
  • Reliable assessment of pathogen load
  • Non-invasive analysis

Evonik releases a new service product group that enables poultry producers to improve livestock production by monitoring the microbial status of entire flocks. ScreenFloX® is the only environmental screening system that non-invasively quantifies the levels of certain pathogens, including Clostridium perfringens, from an entire flock with a confidence exceeding 90%. Evonik launches new ScreenFloX® service at WVPAC in Bangkok

The ScreenFloX® platform comprises a broad range of tests and is designed to help veterinarians, livestock production managers and farmers make smarter decisions to ensure animal well-being and food safety.

Dr. Christoph Kobler, Head of Product Line Sustainable Healthy Nutrition from Evonik said: “Current common practice in animal diagnostics involves testing individual animals using invasive methods. This includes necropsy, histopathology and confirmatory testing which can easily take several days and are expensive.

“ScreenFloX® is an environmental screening system that enables poultry producers to detect levels of different pathogens for the entire flock using an unbiased, non-invasive method. The goal of using ScreenFloX® is to optimize overall livestock production through an ‘early warning system’. This gives producers the chance to react before it is too late to adjust the production process.”

The ScreenFloX® platform can perform multiple tests using a single sample and with minimal additional effort. Combining environmental screenings for avian and human pathogens saves costs and time for poultry producers.

Company Information

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around
€4.6 billion in 2018.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.